|
Volume 6969:(1),1170 January 2008 |
Volume 69 Supplements |
Volume 6868:(10),14601625 October 2007 68:(9),13231451 September 2007 68:(8),11621314 August 2007 68:(7),9881153 July 2007 68:(6),817980 June 2007 68:(5),652809 May 2007 68:(4),500644 April 2007 68:(3),351491 March 2007 68:(2),184343 February 2007 68:(1),1170 January 2007 |
Volume 68 SupplementsSupplement 14, Raising the Bar in Schizophrenia by Treating to Remission Supplement 13, Narcolepsy and Excessive Daytime Sleepiness:From the Bench to the Bedside Supplement 12, Weighing the Evidence: Weight Management Insights for Treating Major Mental Illness Supplement 11, Attention-Deficit/Hyperactivity Disorder and Comorbid Substance Use Disorder Supplement 10, The Role of Folate in Depression and Dementia Supplement 9, Special Issues Related to the Management of Bipolar Disorder in Women: Tolerability of Treatment Supplement 8, Monoamine Oxidase Inhibitors Revisited: Their Role in Depressive Disorders Supplement 7, Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap Supplement 6, The Art and Science of Switching Antipsychotic Medications Supplement 5, Understanding Neuronal Pathways: Novel Targets for the Management of Insomnia Supplement 4, Strategies to Integrate Physical Health Care Into Mental Health Supplement 3, Atypical Depression: Management Challenges and New Treatment Advances Supplement 2, European Study of the Epidemiology of Mental Disorders (ESEMeD): Benefit to the Community in Depression and Anxiety Supplement 1, Evaluating the Evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and Beyond |
Volume 6767:(12),18292052 December 2006 67:(11),16651824 November 2006 67:(10),14831656 October 2006 67:(9),13191479 September 2006 67:(8),11671318 August 2006 67:(7),10081166 July 2006 67:(6),8461007 June 2006 67:(5),684845 May 2006 67:(4),505683 April 2006 67:(3),337504 March 2006 67:(2),174336 February 2006 67:(1),1173 January 2006 |
Volume 67 SupplementsSupplement 14, Practical Pharmacotherapeutic Management Strategies for Patients With Alcohol Dependence Supplement 13, Psychiatry in Brief: Insomnia and Emerging Therapies: Treating the Whole Patient Supplement 12, Social Anxiety Disorder: Diagnosis, Outcome, Mechanisms, and Management Supplement 11, Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD): A Clinical View Supplement 10, Treatment of Agitation Across Mental Disorders Supplement 9, Improving Cognitive Function and Functional Outcome in Severe Mental Illness Supplement 8, New Developments in the Treatment of Attention-Deficit/Hyperactivity Disorder Supplement 7, The Challenges of Dual Diagnosis: Managing Substance Abuse in Severe Mental Illness Supplement 6, The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment Supplement 5, Managing Nonadherence in Schizophrenia: The Role of Long-Acting Agents Supplement 4, Antidepressant Discontinuation Syndrome: Current Perspectives and Consensus Recommendations for Management Supplement 3, The Alzheimers Disease Continuum: From Neuropathology to Clinical Practice Supplement 2, After the Tsunami: Mental Health Challenges to the Community for Today and Tomorrow Supplement 1, The Recognition and Management of Bipolar Disorder With Comorbid Anxiety |
Volume 6666:(12),15021653 December 2005 66:(11),13451501 November 2005 66:(10),12011344 October 2005 66:(9),10861200 September 2005 66:(8),9601085 August 2005 66:(7),812959 July 2005 66:(6),666811 June 2005 66:(5),550665 May 2005 66:(4),408549 April 2005 66:(3),277407 March 2005 66:(2),144276 February 2005 66:(1),1143 January 2005 |
Volume 66 SupplementsSupplement 10, The Management of Autism and Its Related Disorders Supplement 9, Sleep: New Frontiers in Psychiatry and Primary Care Supplement 8, New Therapies for Treatment-Resistant Depression and Anxiety Supplement 7, Developmental Neurobiology and Psychiatry: Challenges and Best Practices for Studies in Children and Adolescents Supplement 6, Medical Comorbidity in Patients With Schizophrenia Supplement 5, The Burden of Bipolar Illness Supplement 4, New Insights Into the Nature and Treatment of Panic Disorder Supplement 3, The Role of Atypical Antipsychotics in the Treatment of Bipolar Disorder Supplement 2, Utilizing Benzodiazepines in Clinical Practice: An Evidence-Based Discussion Supplement 1, New Perspectives in Treating Bipolar Disorder |
Volume 6565:(12),15871763 December 2004 65:(11),14411586 November 2004 65:(10),12941440 October 2004 65:(9),11581293 September 2004 65:(8),10291157 August 2004 65:(7),8901028 July 2004 65:(6),734889 June 2004 65:(5),592733 May 2004 65:(4),456591 April 2004 65:(3),287455 March 2004 65:(2),144286 February 2004 65:(1),1143 January 2004 |
Volume 65 SupplementsSupplement 18, Metabolic Issues in Patients With Psychiatric Disorders Supplement 17, The Dual-Action Debate: Does Pharmacology Matter? Supplement 16, Differential Diagnosis and Management of Daytime Sleepiness and Nighttime Wakefulness Supplement 15, Bipolar Care: Optimal Therapeutic Interventions Based on New Strategies Supplement 14, Beyond Refractory Obsessions and Anxiety States: Towards Remission Supplement 13, New Perspectives for Treating Generalized Anxiety Disorder Supplement 12, Recognizing the Physical Symptoms of Depression Supplement 11, Clinical Effectiveness of Atypical Antipsychotics in Dementia Supplement 10, Managing Bipolar Depression Supplement 9, Drug-Induced Movement Disorders Supplement 8, Changing How We Think About Insomnia: Confronting Clinical Challenges Supplement 7, Psychiatry in Brief: Antipsychotic-Induced Weight Gain and Metabolic Abnormalities: Implications for Increased Mortality in Patients With Schizophrenia Supplement 6, Atypical Antipsychotics in the Treatment of Children and Adolescents Supplement 5, Revisiting the Use of High-Potency Benzodiazepines Supplement 4, Pharmacologic Treatments of Major Depression: Are Two Mechanisms Really Better Than One? Supplement 3, Diagnosing and Treating Attention-Deficit/Hyperactivity Disorder in Adults Supplement 2, The Expert Consensus Guideline Series Using Antipsychotic Agents in Older Patients Supplement 1, Update on Posttraumatic Stress Disorder |
Volume 6464:(12),14051556 December 2003 64:(11),12791404 November 2003 64:(10),11421278 October 2003 64:(9),9791141 September 2003 64:(8),860978 August 2003 64:(7),742859 July 2003 64:(6),623741 June 2003 64:(5),495622 May 2003 64:(4),352494 April 2003 64:(3),227351 March 2003 64:(2),107226 February 2003 64:(1),1106 January 2003 |
Volume 64 SupplementsSupplement 19, Ziprasidone in Schizophrenia: From Acute Treatment to Long-Term Management Supplement 18, Treating Depression: New Choices for a Chronic Problem Supplement 17, The Case for Physician Choice: Implications for Restricted Formularies Supplement 16, Partial Compliance: The Need for Long-Acting Atypical Antipsychotics Supplement 15, Treating Depression and Anxiety to Remission Supplement 14, Optimizing Wakefulness in Patients With Fatigue and Executive Dysfunction Supplement 13, Recent Developments in Achieving Depression Remission Supplement 12, The Expert Consensus Guidelines Series: Optimizing Pharmacologic Treatment of Psychotic Disorders Supplement 11, Long-Term Safety of Methylphenidate in the Treatment of ADHD: Dispelling the Myths and Misconceptions About Stimulant Therapy Abuse Supplement 10, Erectile Dysfunction and Comorbid Depression: Prevalence, Treatment Strategies, and Associated Medical Conditions Supplement 9, Noncholinergic Treatments for Alzheimer's Disease Supplement 8, Using the Newer Pharmacotherapeutic Agents as Mood Stabilizers in Bipolar Spectrum Disorders Supplement 7, Physical Symptoms of Depression and Their Impact on Patients and Society Supplement 6, Bipolar Disorder: Origin, Recognition, and Treatment Supplement 5, Achieving Success in the Management of Bipolar Disorder: Is Lithium Sufficient? Supplement 4, Management of Aggression Across the Life Cycle Supplement 3, The Role of GABA in Neuropsychiatric Disorders: A Review of GABA Agents Supplement 2, Treating Depression and Anxiety to Remission: Use of Algorithms Supplement 1, New Approaches to Managing Difficult-to-Treat Depressions |
Volume 6363:(12),10911214 December 2002 63:(11),9581090 November 2002 63:(10),851957 October 2002 63:(9),753850 September 2002 63:(8),653752 August 2002 63:(7),547652 July 2002 63:(6),464546 June 2002 63:(5),379463 May 2002 63:(4),270378 April 2002 63:(3),176269 March 2002 63:(2),90175 February 2002 63:(1),189 January 2002 |
Volume 63 SupplementsSupplement 14, Anxiety: New Treatment Perspectives Supplement 13, Quetiapine Fumarate: A 5-Year Review Supplement 12, Novel Treatments for Attention-Deficit/Hyperactivity Disorder in Children and Adults Supplement 11, Pathophysiology of Depression: The Emerging Role of Substance P Supplement 10, Long-Term Use of Mood Stabilizers in Bipolar Disorder Supplement 9, Cardiovascular and Metabolic Risks Associated With Schizophrenia and Antipsychotic Drug Treatment Supplement 8, Global Research in Anxiety and Depression (GRAD) Network Consensus Conference Supplement 7, The Use of SSRIs in Depressive Disorders Specific to Women Supplement 6, Exploring the Boundaries of Obsessive-Compulsive Disorder and Other Anxiety Disorders Supplement 5, Treating Sexual Dysfunction: Psychiatry’s Role in the Age of Sildenafil Supplement 4, Clinical Pharmacodynamics and Pharmacokinetics of Antimanic and Mood-Stabilizing Medications Supplement 3, Innovations in the Management of Bipolar Disorders Supplement 2, New Antidepressants: Light at the End of the Tunnel? Supplement 1, Nefazodone: A 6-Year Review |
Volume 6262:(12),9201023 December 2001 62:(11),838919 November 2001 62:(10),744837 October 2001 62:(9),667743 September 2001 62:(8),586666 August 2001 62:(7),496585 July 2001 62:(6),402495 June 2001 62:(5),315401 May 2001 62:(4),219314 April 2001 62:(3),145218 March 2001 62:(2),78144 February 2001 62:(1),177 January 2001 |
Volume 62 SupplementsSupplement 27, Metabolic Disturbances Associated With Antipsychotic Use Supplement 26, Optimizing Outcomes of Treating Depression: Meeting Patient Expectations Supplement 25, Pathways to Suicide Prevention for Bipolar Disorder (CME) Supplement 24, Optimizing Depression Treatments Throughout the Life Cycle (CME) Supplement 23, Effects of Atypical Antipsychotics on Body Weight and Glucose Regulation (CME) Supplement 22, The Role of Enteric-Coated Fluoxetine Once-Weekly In Achieving Optimal Outcomes in the Long-Term Treatment of Depression Supplement 21, Restoring Harmony—Adding Life to Years: Behavioral and Psychological Symptoms of Dementia Supplement 20, Pharmacologic Treatment of Alcohol Abuse and Addiction Supplement 19, Defining Remission in Generalized Anxiety Disorder Supplement 18, Management of Treatment-Resistant Depression (CME) Supplement 17, Understanding Posttraumatic Stress Disorder Supplement 16, Recognizing Treatment-Resistant Depression (CME) Supplement 15, Depression: The Relevance of the Time Factor Supplement 14, The Role of Anticonvulsants as Mood Stabilizers (CME) Supplement 13, Focus on Transcultural Issues in Depression and Anxiety Supplement 12, Remission of Anxiety-Related Disorders (CME) Supplement 11, Focus on Generalized Anxiety Disorder Supplement 10, New Developments for Treating Sleep Disorders Supplement 9, Evaluating Clinical Trial Data From Schizophrenia Research Supplement 8, Focus on Depression and Anxiety Disorders in General Medicine Supplement 7, Weight Gain: A Growing Problem in Schizophrenia Management Supplement 6, Chronic Major Depression: A Review and Update Supplement 5, Comparison of the Bioequivalence of Generic Versus Branded Clozapine Supplement 4, Early Onset of Antidepressant Action Supplement 3, Sexual Dysfunction Associated With Depression and its Treatment (CME) Supplement 2, Olanzapine: Positive Symptom Efficacy and Safety Supplement 1, Advances and Emerging Treatments in Social Phobia |
Volume 6161:(12),892994 December 2000 61:(11),811891 November 2000 61:(10),708810 October 2000 61:(9),626707 September 2000 61:(8),545625 August 2000 61:(7),462544 July 2000 61:(6),399461 June 2000 61:(5),325398 May 2000 61:(4),240324 April 2000 61:(3),159239 March 2000 61:(2),75158 February 2000 61:(1),174 January 2000 |
Volume 61 SupplementsSupplement 14, Acute Care of the Agitated Psychotic Patient Supplement 13, Epidemiology, Etiology, and Treatment of Geriatric Mania Supplement 12, New Trends in Treating Premenstrual Dysphoric Disorder (CME) Supplement 11, New Strategies for Improving the Treatment of Depression (CME) Supplement 10, Norepinephrine: Neurotransmitter for the Millennium Supplement 9, Fifty Years of Lithium Use in the Treatment of Bipolar Disorder (CME) Supplement 8, Side Effects of Antipsychotics (CME) Supplement 7, New Strategies for the Treatment of Posttraumatic Stress Disorder (CME) Supplement 6, Understanding Depression (CME) Supplement 5, Focus on Posttraumatic Stress Disorder Supplement 4, Update on Tardive Dyskinesia (CME) Supplement 3, Antipsychotic Standard of Care: Redefining the Definition of Atypical Antipsychotics (CME) Supplement 2, Optimizing Treatment Outcome in Depression Supplement 1, Spectrum of Depression: New Treatment Approach |
Volume 6060:(12),811907 December 1999 60:(11),728810 November 1999 60:(10),645727 October 1999 60:(9),570644 September 1999 60:(8),504569 August 1999 60:(7),423503 July 1999 60:(6),354422 June 1999 60:(5),279353 May 1999 60:(4),211278 April 1999 60:(3),138210 March 1999 60:(2),72137 February 1999 60:(1),171 January 1999 |
Volume 5959:(12),640719 December 1998 59:(11),564639 November 1998 59:(10),498563 October 1998 59:(9),445497 September 1998 59:(8),399444 August 1998 59:(7),341398 July 1998 59:(6),275340 June 1998 59:(5),213274 May 1998 59:(4),147212 April 1998 59:(3),99146 March 1998 59:(2),4598 February 1998 59:(1),144 January 1998 |
Volume 5858:(12),518578 December 1997 58:(11),466517 November 1997 58:(10),419465 October 1997 58:(9),379418 September 1997 58:(8),337378 August 1997 58:(7),285336 July 1997 58:(6),245286 June 1997 58:(5),181244 May 1997 58:(4),135180 April 1997 58:(3),92134 March 1997 58:(2),4591 February 1997 58:(1),144 January 1997 |
Volume 5757:(12),562626 December 1996 57:(11),504561 November 1996 57:(10),439503 October 1996 57:(9),385438 September 1996 57:(8),327384 August 1996 57:(7),271326 July 1996 57:(6),231270 June 1996 57:(5),182230 May 1996 57:(4),140181 April 1996 57:(3),97139 March 1996 57:(2),5396 February 1996 57:(1),152 January 1996 |
Volume 5656:(12),547604 December 1995 56:(11),500546 November 1995 56:(10),446499 October 1995 56:(9),388445 September 1995 56:(8),336387 August 1995 56:(7),281335 July 1995 56:(6),226280 June 1995 56:(5),175225 May 1995 56:(4),126174 April 1995 56:(3),85125 March 1995 56:(2),5084 February 1995 56:(1),149 January 1995 |
Volume 5555:(12),513563 December 1994 55:(11),468512 November 1994 55:(10),422467 October 1994 55:(9),377421 September 1994 55:(8),320376 August 1994 55:(7),280319 July 1994 55:(6),232279 June 1994 55:(5),177231 May 1994 55:(4),132176 April 1994 55:(3),84131 March 1994 55:(2),4283 February 1994 55:(1),141 January 1994 |
Volume 5454:(12),455515 December 1993 54:(11),403454 November 1993 54:(10),361402 October 1993 54:(9),325360 September 1993 54:(8),283324 August 1993 54:(7),241282 July 1993 54:(6),207240 June 1993 54:(5),175206 May 1993 54:(4),131174 April 1993 54:(3),79130 March 1993 54:(2),4578 February 1993 54:(1),144 January 1993 |
